Additionally, the publication of clinical guidelines by leading gastroenterological societies in Western countries has legitimized the use of ESD for treating early-stage gastric, esophageal, and ...

For large colonic adenomas, endoscopic submucosal dissection (ESD) reduces the local recurrence rate compared with endoscopic mucosal resection (EMR), but the adverse event rate is higher. In ...

The endoscopic submucosal dissection (ESD) market is expanding at a steady CAGR of ~6%, driven by the increasing prevalence of gastrointestinal cancers and a growing preference for minimally invasive ...

Endoscopic submucosal dissection (ESD) of large colorectal adenomas resulted in a lower recurrence rate compared with endoscopic mucosal resection (EMR), but the more technically complex ESD had a ...

Endoscopic submucosal dissection (ESD) represents a significant advance in therapeutic endoscopy with the major advantage being the ability to achieve a higher en bloc resection rate for early stage ...

A prospective clinical trial from researchers in Japan shows magnetic-anchor-guided endoscopic submucosal dissection for large early gastric cancer to be a feasible and safe method in humans.

Both endoscopic submucosal dissection and endoscopic mucosal resection were found to be highly effective for endoscopic resection of early Barrett’s esophagus neoplasia and compared similarly ...

Duodenal lesions (benign, dysplastic or neoplastic) are rare. Symptoms include nausea and vomiting, loss of appetite and weight, anaemia and abdominal pain. Lesions in people who have inherited ...

DELRAY BEACH, Fla., Aug. 27, 2025 /PRNewswire/ -- The global Endoscopic Submucosal Dissection Market, valued at US$0.46 billion in 2024, stood at US$0.50 billion in 2025 and is projected to advance at ...